(Q54375914)

29 May 2018

title

Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients. (English)

1 reference

29 May 2018

1 reference

Kenneth V. I. Rolston

1

object named as

K V Rolston

1 reference

29 May 2018

author name string

D H Ho

2

1 reference

29 May 2018

B LeBlanc

3

1 reference

29 May 2018

G Gooch

4

1 reference

29 May 2018

G P Bodey

5

1 reference

29 May 2018

publication date

1 October 1988

1 reference

29 May 2018

European Journal of Clinical Microbiology & Infectious Diseases

published in

1 reference

29 May 2018

volume

7

1 reference

29 May 2018

issue

5

1 reference

29 May 2018

page(s)

684-686

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01964255

exact match

0 references

cites work

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

https://api.crossref.org/works/10.1007%2FBF01964255

Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01964255

Enoxacin in the treatment of lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01964255

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01964255

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01964255

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01964255

In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01964255

Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3143585

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3143585

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF01964255

1 reference

29 May 2018

1 reference

29 May 2018